Closed and laparoscopic #HIPEC techniques using controlled intra-abdominal pressure via the COMBAT PRS+ (peritoneal recirculation system) improve drug penetration into the tumour and peritoneum. #medicalinnovation #coloncancer #ovariancancer #pancreaticcancer #CombatCancer.

The COMBAT PRS+ is the only peritoneal recirculation system with CO2 agitation to optimise #HIPEC. Automatic agitation ensures homogenous drug & thermal distribution throughout the abdominal cavity and peritoneal surfaces to maximise safety and patient outcomes. #CombatCancer.

Pleased to be showcasing the capabilities of our Combat PRS+ CO2 agitation system for #HIPEC, .together with our partner Nipro Colombia at the 1st Columbian Surgical Oncology Congress in Bogota. #medicalinnovation #colorectalcancer #ovariancancer #pancreaticcancer #CombatCancer

Everything you need to know about the @HIVEC_HEAT trial for BCG-unresponsive NMIBC, using our Combat BRS hyperthermic technology - enjoy!.#medicalinnovation #HIVEC #CombatCancer.

The @HIVEC_HEAT phase 3 trial has 2 sub-studies: carcinoma in situ (n=123) & without carcinoma in situ (n=115), total n=238. Patients will have 40mg MMC medac for 1 hr using Combat BRS #HIVEC® for 15 recirculations over 1 yr & follow-ups at 15, 18, 21, 24 mths. #bladdercancer.

The open-label @HIVEC_HEAT phase 3 trial will cover up to 25 UK sites, with a minimum of 5 participants recruited per year for most sites. There is no randomisation – it’s difficult to randomise against cystectomy. #medicalinnovation #HIVEC #bladdercancer #HIVECHEAT #CombatCancer.

The @HIVEC_HEAT phase 3 trial will assess the effectiveness of our hyperthermic intravesical chemotherapy (HIVEC®) treatment with 80mg mitomycin medac as an alternative to radical cystectomy in BCG-unresponsive, NMIBC. #medicalinnovation #HIVEC #bladdercancer #CombatCancer.

Our interview series with leading clinicians in urology & surgical oncology covers treatments and future directions in bladder, colorectal, ovarian and pancreatic cancer – all areas where we are making a difference with our #HIVEC® and #HIPEC treatments.

New-onset diabetes increases #pancreaticcancer risk by 6-8x. A new study suggests MRI may aid early detection. Currently, only 20% are diagnosed at stage 1, when the 5-year survival rate is 44%. 👉#bigstepforward2025 #HIPEC #CombatCancer.

Did you know that HIPEC with gemcitabine administered by Combat PRS+ has been found to significantly reduce locoregional recurrence in #PancreaticCancer?. #HIPEC #TheBigStepForward2025 #CombatCancer.

This month in the UK, thousands of people will be taking part in @PancreaticCanUK's Big Step Forward. The aim is to help transform the future for those affected by #pancreaticcancer by walking their chosen route to raise awareness and funding for research. #HIPEC #CombatCancer.

Breaking news! The FDA has just given "breakthrough device designation" to a new urine test for #bladdercancer, based on analysis of volatile organic compounds using gas chromatography-mass spectrometry and AI. #medicalinnovation #HIVEC #HIVECHEAT #CombatCancer.

In a recent study, drinkers with high daily intake of alcohol and high drinking frequency have the greatest risk of #colorectalcancer, suggesting that total alcohol intake is the critical factor. #CancerPreventionActionWeek2025 #HIPEC #CombatCancer.

A new study has found a modest but significant association between consumption of beer and spirits and an increased risk of pancreatic cancer, regardless of sex and smoking status. Find out more: #HIPEC #pancreaticcancer #CombatCancer.

Great news for the @HIVEC_HEAT trial for Combat Medical HIVEC® with mitomycin medac for BCG-unresponsive non-muscle-invasive bladder cancer!.#medicalinnovation #HIVEC #CombatCancer.

Alcohol is broken down by the body into acetaldehyde, which induces DNA damage. In 2009, @IARCWHO classed acetaldehyde included in or generated endogenously from alcoholic beverages as a Group 1 human carcinogen. #CancerPreventionActionWeek #bowelcancer.#HIPEC #CombatCancer.

This week is @WCRF_UK's #CancerPreventionActionWeek, which is highlighting the strong evidence that alcohol can increase the risk of 7 different types of cancer, including #bowelcancer. Around 6% of bowel cancers in the UK are caused by alcohol intake. #HIPEC #CombatCancer.

Latest news on the @HIVEC_HEAT phase 3 trial for BCG-unresponsive, non-muscle-invasive #bladdercancer – assessing the effectiveness of our hyperthermic intravesical chemotherapy (HIVEC®) treatment with 80mg mitomycin medac as an alternative to radical cystectomy. #CombatCancer.

If you’ve not already visited us at #BAUS25, Stand B26, pop over today to find out more about our Combat BRS #HIVEC® treatment & the phase 3 @HIVEC_HEATtrial for BCG-unresponsive NMIBC from chief investigator Prof Leyshon Griffiths @trlgriffiths.#bladdercancer #CombatCancer.

Visit us at #BAUS25, Stand B26, tomorrow to find out more about our Combat BRS #HIVEC® treatment & the phase 3 @HIVEC_HEATtrial for BCG-unresponsive NMIBC from chief investigator Prof Leyshon Griffiths @trlgriffiths.#bladdercancer #CombatCancer.